基本信息
浏览量:177
职业迁徙
个人简介
Through the study and development of technologies that overcome current translational hurdles, Dr. Vandenberghe is helping to position gene therapy as a broadly applicable clinical modality in ophthalmology. Previously, he developed a novel adeno-associated viral vector (AAV) platform, and in translational studies, he characterized those for safety and efficacy parameters in large animal models. His current research focuses on gene therapy for neurosensory disorders, especially retinal blindness. He is on the editorial board of Molecular Therapy and is an active member of the American Society of Cell and Gene Therapy, for which he chairs the educational committee. In addition, he co-founded GenSight Biologics, a biotech entity that pursues innovative ocular gene therapy strategies.
研究兴趣
论文共 306 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
MOLECULAR THERAPYno. 4 (2023): 631-631
引用0浏览0引用
0
0
MOLECULAR THERAPYno. 4 (2023): 636-637
引用0浏览0引用
0
0
Gregory A. Newby,Daniel Reichart, Hiroko Wakimoto,Mingyue Lun, Joshua M. Gorham, Justin J. Curran,Aditya Raguram,Daniel M. DeLaughter,David Conner, Julia D. C. Marsiglia,Sajeev Kohli, Lukas Chmatal,
MOLECULAR THERAPYno. 4 (2023): 111-111
引用0浏览0引用
0
0
Daniel Reichart,Gregory A. Newby,Hiroko Wakimoto,Mingyue Lun,Joshua M. Gorham, Justin J. Curran,Aditya Raguram,Daniel M. DeLaughter,David A. Conner, Júlia D. C. Marsiglia,Sajeev Kohli, Lukas Chmatal,
iScienceno. 4 (2022): 104101
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn